Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Visani

Showing results (121-130 of 211) with videos related to

Pageof 22
Sort By:
Cancer Research|July 15, 1990
In vitro bone marrow purging of multidrug-resistant cells with a mouse monoclonal antibody directed against Mr 170,000 glycoprotein and a saporin-conjugated anti-mouse antibodyA Dinota, P L Tazzari, M Michieli, et al.
Haematologica|November 1, 1994
Ifosfamide, epirubicin and etoposide (IEV) therapy in relapsed and refractory high-grade non-Hodgkin's lymphoma and Hodgkin's diseaseP L Zinzani, E Barbieri, G Visani, et al.
Leukemia & Lymphoma|June 1, 1996
FLANG (fludarabine + cytosine arabinoside + novantrone + G-CSF) induces partial remission in lymphoid blast transformation of Ph+chronic myelogenous leukaemiaG Martinelli, N Testoni, E Zuffa, et al.
Leukemia & Lymphoma|November 1, 1995
MEC (mitoxantrone, etoposide and intermediate dose cytarabine): an effective induction regimen for previously untreated acute non-lymphocytic leukemiaG Visani, M C Petti, A Cenacchi, et al.
Leukemia|October 30, 2001
Pulsed ATRA as single therapy restores long-term remission in PML-RARalpha-positive acute promyelocytic leukemia patients: real time quantification of minimal residual disease. A pilot studyG Visani, S Buonamici, M Malagola, et al.
Bone Marrow Transplantation|July 1, 1994
Acute myeloid leukemia from diagnosis to bone marrow transplantation: experience from a single centreB Gamberi, G Bandini, G Visani, et al.
American Journal of Hematology|December 1, 1994
Apoptosis induction with three nucleoside analogs on freshly isolated B-chronic lymphocytic leukemia cellsP L Zinzani, P Tosi, G Visani, et al.
Bone Marrow Transplantation|December 1, 1989
Low-dose Ara-C plus granulocyte/macrophage colony-stimulating factor for the treatment of myelodysplastic syndromes. EORTC Leukemia GroupH H Gerhartz, G Visani, A Delmer, et al.
European Journal of Haematology|May 1, 1996
FLAG (fludarabine, cytarabine, G-CSF) as a second line therapy for acute lymphoblastic leukemia with myeloid antigen expression: in vitro and in vivo effectsG Visani, P Tosi, P L Zinzani, et al.
British Journal of Haematology|October 1, 1995
Interleukin-11 (IL-11) acts as a synergistic factor for the proliferation of human myeloid leukaemic cellsR M Lemoli, M Fogli, A Fortuna, et al.
Pageof 22

Showing results (121-130 of 211) with videos related to

Sort By:
Pageof 22
Cancer Research|July 15, 1990
In vitro bone marrow purging of multidrug-resistant cells with a mouse monoclonal antibody directed against Mr 170,000 glycoprotein and a saporin-conjugated anti-mouse antibodyA Dinota, P L Tazzari, M Michieli, et al.
Haematologica|November 1, 1994
Ifosfamide, epirubicin and etoposide (IEV) therapy in relapsed and refractory high-grade non-Hodgkin's lymphoma and Hodgkin's diseaseP L Zinzani, E Barbieri, G Visani, et al.
Leukemia & Lymphoma|June 1, 1996
FLANG (fludarabine + cytosine arabinoside + novantrone + G-CSF) induces partial remission in lymphoid blast transformation of Ph+chronic myelogenous leukaemiaG Martinelli, N Testoni, E Zuffa, et al.
Leukemia & Lymphoma|November 1, 1995
MEC (mitoxantrone, etoposide and intermediate dose cytarabine): an effective induction regimen for previously untreated acute non-lymphocytic leukemiaG Visani, M C Petti, A Cenacchi, et al.
Leukemia|October 30, 2001
Pulsed ATRA as single therapy restores long-term remission in PML-RARalpha-positive acute promyelocytic leukemia patients: real time quantification of minimal residual disease. A pilot studyG Visani, S Buonamici, M Malagola, et al.
Bone Marrow Transplantation|July 1, 1994
Acute myeloid leukemia from diagnosis to bone marrow transplantation: experience from a single centreB Gamberi, G Bandini, G Visani, et al.
American Journal of Hematology|December 1, 1994
Apoptosis induction with three nucleoside analogs on freshly isolated B-chronic lymphocytic leukemia cellsP L Zinzani, P Tosi, G Visani, et al.
Bone Marrow Transplantation|December 1, 1989
Low-dose Ara-C plus granulocyte/macrophage colony-stimulating factor for the treatment of myelodysplastic syndromes. EORTC Leukemia GroupH H Gerhartz, G Visani, A Delmer, et al.
European Journal of Haematology|May 1, 1996
FLAG (fludarabine, cytarabine, G-CSF) as a second line therapy for acute lymphoblastic leukemia with myeloid antigen expression: in vitro and in vivo effectsG Visani, P Tosi, P L Zinzani, et al.
British Journal of Haematology|October 1, 1995
Interleukin-11 (IL-11) acts as a synergistic factor for the proliferation of human myeloid leukaemic cellsR M Lemoli, M Fogli, A Fortuna, et al.
Pageof 22